SCHEMBL27136382

SCHEMBL27136382

Cc1cc(CCC=O)ncc1-c1cc2cnc(Cl)cc2c2ncoc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27147882 0.92
SCHEMBL30780301 0.78 ABL1 (0.32)
SCHEMBL27145381 0.78 S1PR2 (0.30)
SCHEMBL30780206 0.69 ABL1 (0.32)
SCHEMBL27140441 0.66 CSNK2A1 (0.37)
SCHEMBL31613256 0.66 CSNK2A1 (0.37)
SCHEMBL27145458 0.65
SCHEMBL27149479 0.63 S1PR2 (0.32)
SCHEMBL24666913 0.60 FGFR1 (0.41)
SCHEMBL24665035 0.57 FGFR1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4577546-A1 NAPHTHYRIDINE COMPOUNDS FOR INHIBITION OF RAF KINASES Enliven Inc. (US) 2025-07-02 EP disclosed
WO-2024044713-A1 NAPHTHYRIDINE COMPOUNDS FOR INHIBITION OF RAF KINASES ENLIVEN INC. (US) 2024-02-29 WO disclosed